Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2007 September;59(3) > Minerva Urologica e Nefrologica 2007 September;59(3):367-77

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536


eTOC

 

REVIEWS  HOT TOPICS IN NEPHROLOGY IN 2007


Minerva Urologica e Nefrologica 2007 September;59(3):367-77

language: English

Immune monitoring after kidney transplantation

Gerrits J. H., Weimar W., Van Besouw N. M.

Department of Internal Medicine-Transplantation, Erasmus MC University Medical Center Rotterdam Rotterdam, The Netherlands


PDF  


During the last decennium, research in the field of organ transplantation changed from studying mechanisms of acute rejection shortly after transplantation to understanding why patients benefit from their grafts only for a limited time, because of irreversible chronic rejection and serious side effects of immunosuppression. To avoid side effects, tapering or even withdrawal of immunosuppression in transplant recipients is warranted, provided this is not accompanied with graft loss. Noninvasive cell mediated immune tests could be helpful to identify transplant recipients in whom the immunosuppressive load can be safely reduced, and to identify patients at risk for chronic rejection. In the present report, we describe cellular assays to determine donor-specific responses in peripheral blood mononuclear cells from transplant recipients taken before transplantation and during tapering or withdrawal of immunosuppression.

top of page

Publication History

Cite this article as

Corresponding author e-mail